Mkts

Design Therapeutics, Inc.

NASDAQ: DSGN
$10.22-0.25 (-2.39%)
As of Nov 16, 10:18 AM ET

Key statistics

Day range
10.1610.53
52-week range
6.8117.25
Today
Open10.52
Previous close10.22
Volume—
Valuation
Market cap670.46M
P/E ratio—
EPS (TTM)-1.20
Income & risk
Dividend / yield—
Beta1.68
Avg volume552.4K
Discussion

DSGN News

Stories mentioning DSGN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.00
Cost of Goods Sold
Gross Profit0.000.000.000.00
Operating Expenses
Research & Development14,37913,42514,58915,73815,37712,15711,87610,516
Sales General & Admin
Total Operating Expenses19,70618,16919,31121,56920,41816,69416,24615,043
Operating Income (Loss)(19,706)(18,169)(19,311)(21,569)(20,418)(16,694)(16,246)(15,043)
Interest Income2,0702,1722,3142,4862,7033,0433,2073,250
Interest Expense
Other Expense3,2073,250
Pretax Income
Tax Provision
Net Income (Loss)(17,636)(15,997)(16,997)(19,083)(17,715)(13,651)(13,039)(11,793)
Earnings Per Share (Basic)(0.29)(0.28)(0.30)(0.34)(0.31)(0.24)(0.23)(0.21)
Earnings Per Share (Diluted)(0.29)(0.28)(0.30)(0.34)(0.31)(0.24)(0.23)(0.21)
Weighted Average Shares Outstanding (Basic)61,43457,33056,95156,85956,75856,58756,62156,556
Weighted Average Shares Outstanding (Diluted)61,43457,33056,95156,85956,75856,58756,62156,556

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About DSGN

Design Therapeutics, Inc. (NASDAQ: DSGN) is a stock listed on the Nasdaq Stock Market under the ticker symbol DSGN. It last traded at $10.22 (Nov 16, 2026, 10:18 AM ET), down 2.4% on the day. That gives Design Therapeutics a market capitalisation of $670.5M.

Over the past 52 weeks DSGN has traded between $6.81 and $17.25.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $17.6M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$0-$17.6M
Dec 31, 2025—-$16.0M
Sep 30, 2025—-$17.0M
Jun 30, 2025—-$19.1M

From Design Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…